Clinical trial
A Double-Blind, Randomised, Exploratory Study to Investigate the Safety, Efficacy and Pharmacokinetics of PRX167700 in Subjects With Knee Osteoarthritis.
NCT01945346 is registered in ClinicalTrials.gov with Proximagen Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Randomised, Exploratory Study to Investigate the Safety, Efficacy and Pharmacokinetics of PRX167700 in Subjects With Knee Osteoarthritis.
- Lead sponsor
- Proximagen Limited
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- April 30, 2015
- Enrollment
- 74 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.